Leukocyte ADAM17 and Lung Inflammation
Author Information
Author(s): Arndt Patrick G., Strahan Brian, Wang Yue, Long Chunmei, Horiuchi Keisuke, Walcheck Bruce
Primary Institution: University of Minnesota
Hypothesis
ADAM17 may have an important regulatory function in pulmonary inflammation.
Conclusion
Leukocyte ADAM17 promotes inflammation in the lung and may be a potential target for therapies for acute lung injury.
Supporting Evidence
- ADAM17-null mice showed significantly reduced levels of alveolar TNF-α after LPS exposure.
- Neutrophil recruitment to the alveolar compartment was altered in ADAM17-null mice.
- ADAM17 is the primary sheddase of L-selectin and TNF-α in the lung.
Takeaway
ADAM17 helps control how many immune cells get into the lungs when they are inflamed, which is important for treating lung injuries.
Methodology
The study used conditional ADAM17 knock-out mice to investigate the role of leukocyte ADAM17 in acute lung inflammation induced by LPS.
Limitations
The study primarily focused on the role of ADAM17 in leukocytes and did not explore its effects in other cell types.
Participant Demographics
Mice aged 8-12 weeks were used in the experiments.
Statistical Information
P-Value
<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website